Gyre Therapeutics (GYRE) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -422.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -422.13% |
| Dec 31, 2025 | -1,640.40% |
| Sep 30, 2025 | 221.17% |
| Jun 30, 2025 | -87.47% |
| Mar 31, 2025 | -64.18% |
| Dec 31, 2024 | 99.90% |
| Sep 30, 2024 | -71.73% |
| Jun 30, 2024 | 90.39% |
| Mar 31, 2024 | 235.65% |
| Dec 31, 2023 | -237.70% |
| Sep 30, 2023 | 181.41% |
| Jun 30, 2023 | -96.41% |
| Mar 31, 2023 | 115.44% |
| Dec 31, 2022 | -47.27% |
| Sep 30, 2022 | 80.65% |
| Jun 30, 2022 | 359.09% |
| Mar 31, 2022 | 35.22% |
| Dec 31, 2021 | -7.42% |
| Sep 30, 2021 | -57.41% |
| Jun 30, 2021 | -15.54% |
| Mar 31, 2021 | -453.61% |
| Dec 31, 2020 | -38.92% |
| Sep 30, 2020 | -26.18% |
| Jun 30, 2020 | -25.17% |
| Mar 31, 2020 | 73.13% |
| Dec 31, 2019 | -25.59% |
| Sep 30, 2019 | -65.14% |
| Jun 30, 2019 | -112.59% |
| Mar 31, 2019 | -199.15% |
| Dec 31, 2018 | -88.37% |
| Sep 30, 2018 | -32.82% |
| Jun 30, 2018 | 34.05% |
| Mar 31, 2018 | -21.85% |
| Dec 31, 2017 | -53.41% |
| Sep 30, 2017 | -21.42% |
| Jun 30, 2017 | -103.35% |
| Mar 31, 2017 | -15.20% |
| Dec 31, 2016 | 42.37% |
| Sep 30, 2016 | -32.09% |
| Jun 30, 2016 | -11.46% |
| Mar 31, 2016 | 46.80% |
| Dec 31, 2015 | -42.82% |
| Sep 30, 2015 | 25.68% |
| Jun 30, 2015 | 46.71% |
| Mar 31, 2015 | 54.98% |
| Dec 31, 2014 | 65.90% |
| Sep 30, 2014 | 62.33% |
| Jun 30, 2014 | 34.23% |
| Mar 31, 2014 | -85.95% |
| Dec 31, 2013 | 16.64% |
| Sep 30, 2013 | -63.75% |
| Jun 30, 2013 | -185.36% |
| Mar 31, 2013 | -457.06% |
| Dec 31, 2012 | -63.45% |
| Sep 30, 2012 | 12.98% |
| Jun 30, 2012 | 742.09% |
| Mar 31, 2012 | -82.05% |
| Dec 31, 2011 | -353.10% |
| Sep 30, 2011 | -464.20% |
| Jun 30, 2011 | -159.68% |